Short- and long-term effects of amiodarone on the two components of cardiac delayed rectifier K(+) current

Circulation. 2001 Mar 6;103(9):1317-24. doi: 10.1161/01.cir.103.9.1317.

Abstract

Background: Amiodarone is the most promising drug for the treatment of life-threatening tachyarrhythmias in patients with structural heart disease. The pharmacological effects of amiodarone on cardiac ion channels are complex and may differ for short-term and long-term administration.

Methods and results: The delayed rectifier K(+) current (I(K)) of ventricular myocytes isolated from rabbit hearts was recorded with the whole-cell voltage-clamp technique. I(K) was separated into 2 components by use of specific blockers for either I(Ks) (chromanol 293B, 30 micromol/L) or I(Kr) (E-4031, 10 micromol/L). Short-term application of amiodarone caused a concentration-dependent decrease in I(Kr) with an IC(50) of 2.8 micromol/L (n=8) but only a minimal reduction in I(Ks). The short-term effects of amiodarone were also determined in Xenopus oocytes expressing the cloned human channels that conduct I(Kr) and I(Ks) (HERG and KvLQT1/minK). HERG current in oocytes was reduced by amiodarone (IC(50)=38 micromol/L), whereas KvLQT1/minK current was unaffected by 300 micromol/L amiodarone. To study the effects of long-term drug administration, rabbits were treated for 4 weeks with oral amiodarone (100 mg. kg(-1). d(-1)) before cell isolation. Long-term administration of amiodarone decreased I(K) to 55% (n=10) in control rabbits and altered the relative density of I(Kr) and I(Ks). The majority (92%) of current was I(Kr). mRNA levels of rabbit ERG,KVLQT1, and minK in left ventricular myocardium did not differ between control and long-term amiodarone.

Conclusions: Amiodarone has differential effects on the 2 components of I(K), depending on the application period; short-term treatment inhibits primarily I(Kr), whereas long-term treatment reduces I(Ks).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amiodarone / pharmacology*
  • Animals
  • Cation Transport Proteins*
  • Cells, Cultured
  • Delayed Rectifier Potassium Channels
  • Ether-A-Go-Go Potassium Channels
  • Female
  • Gene Expression Regulation / drug effects
  • Heart Ventricles / cytology
  • Heart Ventricles / drug effects
  • Male
  • Membrane Potentials / drug effects*
  • Myocardium / cytology
  • Myocardium / metabolism
  • Oocytes / drug effects
  • Oocytes / physiology
  • Patch-Clamp Techniques
  • Potassium Channels / genetics
  • Potassium Channels / physiology*
  • Potassium Channels, Voltage-Gated*
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rabbits
  • Time Factors
  • Vasodilator Agents / pharmacology*
  • Ventricular Function
  • Xenopus

Substances

  • Cation Transport Proteins
  • Delayed Rectifier Potassium Channels
  • Ether-A-Go-Go Potassium Channels
  • KCNH6 protein, human
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • RNA, Messenger
  • Vasodilator Agents
  • potassium channel protein I(sk)
  • Amiodarone